Are aBCB1 gene polymorphisms associated with the severity of major depressive disorder and its response to escitalopram treatment?
Our findings suggest that single nucleotide polymorphisms in the ABCB1 gene may be indicators of the severity of depression and of the likely S-CIT treatment remission response in MDD.
The data suggest that the smaller the artery is, the more it will dilate. Further EDAD investigations are needed to predict arteriosclerosis, taking into account of the gender difference in vessel size.